Delivery Order SPE2DR25D2204-SPE2DR26FS22C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors, with a contract ceiling value of $47,910.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $36,136.31 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector units on December 5, 2025, with a completion deadline of December 8, 2025. This firm fixed-price delivery order represents a direct purchase of this specialty pharmaceutical product for use within federal medical supply chains. The contract was competitively awarded with no set-aside provisions, reflecting AmerisourceBergen's established capability to meet...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Enbrel 50 mg/ml SureClick auto-injector pharmaceutical product valued at $75,487.57 by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025. This firm fixed price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive, non-set-aside award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a $67,062.44 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 26, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. The contract, which is a child award under a larger indefinite delivery contract vehicle, carries an ultimate completion date of September 29, 2025, and was competitively awarded with no set-aside designation. Performance will be executed from the company's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,091.40 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents performance at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors, with a ceiling value of $11,222.37. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, for Enbrel 50 mg/ml SureClick auto-injectors with a ceiling value of $4,626.77. This firm fixed-price, non-set-aside contract is funded through the Defense Logistics Agency's Medical Supply Chain and is set to complete by September 24, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting federal medical...
- The Defense Logistics Agency awarded a $18,469.99 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors, valued at $4,626.77. This firm fixed-price delivery order, with an ultimate completion date of June 23, 2025, represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The contract involves no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a $47,976.98 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D2204Indefinite Delivery Contract
- SPE2DR25D2204-SPE2DR26FS22CDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order on December 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Enbrel 50 mg/mL SureClick auto-injectors, valued at $36,316.97. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by December 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 running through December 2026. As a prime pharmaceutical vendor for the DLA, AmerisourceBergen supplies a broad range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. The Enbrel delivery represents part of the company's ongoing portfolio of specialty medications and immunological treatments provided to federal healthcare programs, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.3k | 12/11/25 |